SCHEMBL660364

SCHEMBL660364

CC(C)OC(=O)C1=CN(CC(=O)c2ccccc2)C=CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDCD1 Q15116 1/20 0.43
CD274 Q9NZQ7 1/20 0.43
NPC1 O15118 5/20 0.39
HTT P42858 3/20 0.39
RAB9A P51151 3/20 0.39
ALDH1A1 P00352 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
LMNA P02545 1/20 0.39
KMT2A Q03164 4/20 0.38
MEN1 O00255 3/20 0.38
MAPT P10636 1/20 0.37
F2 P00734 1/20 0.37
PLAU P00749 1/20 0.37
ELANE P08246 1/20 0.37
POLB P06746 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
KDM4E B2RXH2 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL658507 0.86 TSHR (0.42) NPC1HTTRAB9AALDH1A1SMN1; SMN2
SCHEMBL27854995 0.82 ALDH1A1 (0.41) NPC1RAB9AALDH1A1SMN1; SMN2KMT2A
SCHEMBL660962 0.81 KMT2A (0.41) NPC1HTTRAB9AALDH1A1SMN1; SMN2
SCHEMBL660917 0.80 ALDH1A1 (0.40) NPC1RAB9AALDH1A1SMN1; SMN2KMT2A
SCHEMBL298474 0.78 SMN1; SMN2 (0.40) NPC1RAB9AALDH1A1SMN1; SMN2KMT2A
SCHEMBL27871677 0.77 ALDH1A1 (0.38) NPC1RAB9AALDH1A1SMN1; SMN2LMNA
SCHEMBL660154 0.77 SMN1; SMN2 (0.39) NPC1RAB9AALDH1A1SMN1; SMN2KMT2A
SCHEMBL7805087 0.77 HDAC1 (0.40) NPC1RAB9AALDH1A1SMN1; SMN2KMT2A
SCHEMBL27854950 0.74 ADRA2C (0.35) NPC1RAB9AALDH1A1SMN1; SMN2LMNA
SCHEMBL287206 0.73 PTGS2 (0.47) ALDH1A1SMN1; SMN2KMT2AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS DUTT CHAITANYA (IN) 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS AGER, REN, AGT PDCD1 4410/4885CD274 4532/4885NPC1 1176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.